CYTOVAC A/S: Financial statements 2017
CVR: 31262666
Source: annual report 2017, Danish Business Authority
01/01/2017 – 31/12/2017
CYTOVAC A/S (CVR 31262666) has filed annual accounts for 2017. In 2017, the company reported a gross profit of DKK -11,513,425 and a net result of DKK -14,856,795 compared with DKK -12,683,180 the year before. Equity in the 2017 report amounted to DKK 3,518,542. The solvency ratio was 53.4%. The company had 14 employees in the financial year.
- Gross Profit
- DKK -11,513,425
- Profit/Loss
- DKK -14,856,795
- Equity
- DKK 3,518,542
- Total Assets
- DKK 6,590,018
- Employees
- 14
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2017 | - | -11.5M | -14.9M | 3.5M | 14 |
| 2016 | - | -9.1M | -12.7M | 9.3M | 12 |
| 2015 | - | -9.2M | -12.2M | 5.9M | - |
| 2014 | - | -8.1M | -10.8M | 18.1M | - |
| 2013 | - | -6.6M | -10.9M | 1.9M | - |
Official annual report
Keep an eye on CYTOVAC A/S
Get notified instantly about new financial statements, ownership changes, management changes and status changes.
Set up monitoringEvents in 2017
As of October 5, 2017, Kim Arvid Nielsen is registered as adm. dir. of CYTOVAC A/S.
As of October 5, 2017, Martin Roland Jensen has stepped down as director of CYTOVAC A/S.
CYTOVAC A/S has published its annual report for 2016. Gross profit came to DKK -9,087,892, and the net result was DKK -12,683,180.
About CYTOVAC A/S
CYTOVAC A/S was a Danish company of the type Aktieselskab based in København K, founded in 2008. The company has been dissolved on 16 January 2026. The company was registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The company has 2 employees (2024). In 2023, the company reported a net result of DKK -15,319,000 compared with DKK -6,277,000 the year before. Equity in the 2023 report amounted to DKK -88,579,000.